However, large cohort, controlled, and longterm trials in patients with PWS will be required to confirm the efficacy and safety of GLP-1 receptor agonists and analogues
Recent advances in covalent organic framework-based nanosystems for bioimaging and therapeutic applications, ACS mater
Called Byetta (exenatide) and originally developed by Amylin Pharmaceuticals, the drug was later marketed by AstraZeneca
GLP-1 medications can help people lose weight by influencing appetite, satiation, and digestion
Although GLP-1 RAs have demonstrated efficacy and offer hope, obesity remains challenging and individual outcomes vary
No human study has tracked cancer incidence following BPC-157 administration, leaving the oncological risk profile unresolved and requiring cautious evaluation before use in individuals with active or prior malignancies